MPDRX Performance — MassMutual Disciplined Growth Fund, Class R3
Data updated: 2025-08-25
MPDRX returned +15.75% over one year to Jun 2025. Annualised returns are +23.54% over 3 years and +15.87% over 5 years. Against its US Large Growth category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $189, against $184 for the category, and to $116 over one year, against $116. Volatility over the past three years was 18.77% a year. In the 12 months to Jun 2025 the fund took in a net $9.3M, and assets reached $204.40M.
MPDRX Growth of $100
What $100 invested in MassMutual Disciplined Growth Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | MPDRX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $116 | $116 |
| 3 years (Jul 2022 – Jun 2025) | $189 | $184 |
| 5 years (Jul 2020 – Jun 2025) | $209 | $197 |
| Since data start (Jul 2019 – Jun 2025) | $250 | $232 |
MPDRX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +15.75% |
| 3 years (annualised) | +23.54% |
| 5 years (annualised) | +15.87% |
MPDRX Annual Returns
Calendar-year total returns of MassMutual Disciplined Growth Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +5.50% |
| 2024 | +35.83% |
| 2023 | +38.89% |
| 2022 | −32.25% |
| 2021 | +27.16% |
| 2020 | +30.44% |
| 2019 (Jul–Dec) | +11.73% |
MPDRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −8.3% | −3.9% | +1.4% | +1.7% | +9.3% | +6.2% | — | — | — | — | — | — |
| 2024 | +2.8% | +7.2% | +3.3% | +6.1% | +6.8% | −4.0% | +2.4% | +1.5% | −1.6% | +1.5% | +6.2% | −0.4% |
| 2023 | +5.7% | −0.7% | +8.2% | +7.1% | +3.3% | +0.3% | −5.4% | −0.6% | +3.4% | +4.4% | +10.0% | −1.3% |
| 2022 | +2.8% | −4.5% | −8.8% | −8.2% | −1.3% | −11.7% | −10.1% | −6.2% | +12.0% | −8.4% | +4.5% | +4.9% |
| 2021 | +2.2% | +1.4% | −2.1% | +6.0% | −1.0% | +7.0% | −6.0% | +3.6% | +3.8% | +1.6% | +1.4% | +7.2% |
| 2020 | −9.4% | −7.3% | +1.0% | +4.3% | +5.9% | +14.4% | −5.0% | +9.6% | +6.9% | +3.1% | +10.1% | −3.7% |
| 2019 | — | — | — | — | — | — | +0.5% | −1.4% | +2.1% | +3.4% | +3.9% | +2.8% |
MPDRX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 18.77%
- 3-year Sharpe ratio: 1.01 (vs 4.5% risk-free rate)
- Best month: +11.98% (Sep 2022)
- Worst month: −10.13% (Jul 2022)
MPDRX Fund Flows
Monthly money in and out of MassMutual Disciplined Growth Fund, from SEC Form N-PORT.
- 12-month net flow: $9.3M
- 12-month gross sales (incl. reinvestments): $64.6M
- Sales ÷ redemptions: 1.17×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $1.5M | $4.6M | −$3.1M |
| May 2025 | $2.2M | $2.6M | −$407K |
| Apr 2025 | $2.6M | $3.0M | −$424K |
| Mar 2025 | $2.5M | $2.5M | −$87K |
| Feb 2025 | $2.1M | $3.3M | −$1.2M |
| Jan 2025 | $3.0M | $3.4M | −$402K |
| Dec 2024 | $2.5M | $4.6M | −$2.1M |
| Nov 2024 | $2.3M | $7.6M | −$5.3M |
| Oct 2024 | $36.3M | $8.2M | $28.1M |
| Sep 2024 | $4.9M | $4.1M | $885K |
| Aug 2024 | $2.7M | $4.4M | −$1.6M |
| Jul 2024 | $2.0M | $7.0M | −$4.9M |
MPDRX Assets Under Management
Net assets of MassMutual Disciplined Growth Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $204.40M |
| 2025-03-31 | $176.84M |
| 2024-12-31 | $199.47M |
| 2024-09-30 | $197.17M |
| 2024-06-30 | $198.05M |
| 2024-03-31 | $190.69M |
| 2023-12-31 | $171.40M |
| 2023-09-30 | $159.23M |
| 2023-06-30 | $169.02M |
| 2023-03-31 | $161.31M |
| 2022-12-31 | $148.35M |
| 2022-09-30 | $154.76M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.